<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Camptothecins in cancer therapy</title>
  </titleInfo>
  <name type="personal">
    <namePart>Burke, Thomas G.</namePart>
    <namePart type="termsOfAddress">PhD</namePart>
    <role>
      <roleTerm type="text">editor</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Adams, Val R.</namePart>
    <role>
      <roleTerm type="text">editor</roleTerm>
    </role>
  </name>
  <typeOfResource/>
  <genre authority="">Electronic books (Form)</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">nju</placeTerm>
    </place>
    <dateIssued encoding="marc">2005</dateIssued>
    <issuance/>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <reformattingQuality>access</reformattingQuality>
    <extent>xiii, 460 pages : illustrations ; 24 cm.</extent>
  </physicalDescription>
  <tableOfContents>Mechanism of action of topoisomerase I poisons / Leroy F. Liu and Shyamal D. Desai -- Crystallographic insight into the mechanism of drug-induced topoisomerase I DNA damage / Alex B. Burgin, Jr., Bart L. Staker, and Lance Stewart -- Inhibitors of topoisomerase I function / Sidney M. Hecht -- Cytotoxic mechanisms of the topoisomerase I inhibitors / Yves Pommier ... [et al.] -- Biochemical and genetic analyses of DNA topoisomerase I-mediated DNA damage / Robert C.A.M. Van Waardenburg and Mary-Ann Bjornsti -- Preclinical models for evaluating topoisomerase-I targeted drugs / Aarti S. Juvekar ... [et al.] -- Mechanisms of resistance to camptothecins / Zeshaan A. Rasheed and Eric H. Rubin -- Recent advances in camptothecin drug design and delivery strategies / Thomas G. Burke ... [et al.] -- Clinical experience with 9-aminocamptothecin: lessons for new drug development / Chris H. Takimoto -- Clinical studies of rubitecan (9-nitro 20(s) camptothecin) / Hilary Hewes, Judith A. Smith, and Claire Verschraegen -- Irinotecan: current clinical status and pharmacological aspects / Laurent P. Rivory -- Clinical experience with topotecan / Aimee K. Bence and Val R. Adams -- The clinical development of lurtotecan: experience with water-soluble and liposomal forms / Keith T. Flaherty ... [et al.] -- Preclinical and clinical development of dx-8951f (exatecan mesylate): a hexacyclic camptothecin analog / Eric K. Rowinsky -- Camptothecins in the treatment of primary brain tumors / Clinton F. Stewart, Markos Leggas, and Henry S. Friedman -- Camptothecins in the treatment of lung cancer / Pankaj Kumar ... [et al.] -- Use of camptothecins in the treatment of leukemia and related disorders / Bejamin M.F. Mow and Scott H. Kaufmann.</tableOfContents>
  <note type="statement of responsibility">edited by Thomas G. Burke and Val R. Adams</note>
  <note>Includes bibliographical references and index.</note>
  <note>Also available in electronic resource.</note>
  <subject authority="lcsh">
    <topic>Camptothecin</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Cancer</topic>
    <topic>Chemotherapy</topic>
  </subject>
  <classification authority="lcc">RC271.C35</classification>
  <relatedItem type="series">
    <titleInfo>
      <title>Cancer drug discovery and development</title>
    </titleInfo>
  </relatedItem>
  <identifier type="isbn">1588290271 (hardback)</identifier>
  <identifier type="isbn">9781588290274 (hardback)</identifier>
  <identifier type="isbn">9781588290274 (paperback)</identifier>
  <identifier type="isbn">9781588290274 (ebook)</identifier>
  <identifier type="lccn">2004013542</identifier>
  <identifier type="uri">https://link.springer.com/10.1385/1592598668</identifier>
  <location>
    <url>https://link.springer.com/10.1385/1592598668</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">UIAM</recordContentSource>
    <recordCreationDate encoding="marc">051219</recordCreationDate>
    <recordChangeDate encoding="iso8601">20240227120317.0</recordChangeDate>
    <recordIdentifier>  292112</recordIdentifier>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
